APA

Revfunky

That is a very broad question without knowing any supporting information. I don’t know what you invest in? What you are looking for? Your risk tolerance? Oil is the last shoe to drop. You can get there early. I like the cash flow and valuation of APA and you can collect a nice dividend as the share price appreciates. In fact I would go so far as to call it a unicorn stock. Every 5 or 10 years a unicorn stock comes up that can make life changing gains. RYCEY was our last unicorn in 2020 and it turned into a ten-bagger.

Admirable-Sea-8100

Private lawsuits are the bottleneck here, though, and that isn't something Trump can stop by executive order. Congress would need to change the NEPA and/or APA in a way that also preempts CEQA and similar laws, and the Supreme Court would need to uphold it, and that's not going to happen even if Trump wants it to.

CSguyMX

Citation in MLA or APA please

jarkon-anderslammer

APA.

Megaloman-_-

Why not some US pure Shale producer like DVN, APA, SM, OVV, EOG ?

Content_Advice190

[$ARRY](https://stocktwits.com/symbol/ARRY) ARRY Quick Update – UBS Upgrade + Upcoming Investor Meetings 🔥 UBS just raised its price target on ARRY from $9 → $15 and reiterated a Buy rating. UBS says ARRAY is well-positioned to benefit from the upcoming wave of U.S. utility-scale solar demand driven by AI data-center expansion, and they expect continued strength in the order book. 📅 Upcoming investor events to watch: • Jefferies Fireside Chat – Nov 19, 2025 (Virtual) Speaker: Kevin Hostetler (CEO) Usually a key sentiment driver — tone here can move the stock short-term. • UBS Global Technology & AI Conference – Dec 3–4, 2025 (Scottsdale, AZ) Speakers: CFO + Investor Relations team One-on-one meetings with institutions → often where real momentum shifts. These two events + the UBS upgrade could act as near-term catalysts if management stays bullish on backlog, APA integration, and 2026 margins

Content_Advice190

# ARRY Quick Update – UBS Upgrade + Upcoming Investor Meetings **🔥 UBS just raised its price target on ARRY from $9 → $15** and reiterated a **Buy** rating. UBS says ARRAY is *well-positioned* to benefit from the upcoming wave of U.S. utility-scale solar demand driven by AI data-center expansion, and they expect continued strength in the order book. **📅 Upcoming investor events to watch:** # • Jefferies Fireside Chat – Nov 19, 2025 (Virtual) Speaker: **Kevin Hostetler (CEO)** Usually a key sentiment driver — tone here can move the stock short-term. # • UBS Global Technology & AI Conference – Dec 3–4, 2025 (Scottsdale, AZ) Speakers: **CFO + Investor Relations team** One-on-one meetings with institutions → often where real momentum shifts. These two events + the UBS upgrade could act as near-term catalysts if management stays bullish on backlog, APA integration, and 2026 margins.

Content_Advice190

**☀️ ARRY — Bullish Setup (UBS PT $15, +60% Upside)** UBS reaffirmed **Buy** and lifted its target to **$15**, highlighting stronger U.S. utility-scale solar demand, steady backlog growth, and early benefits from the APA acquisition. Margins are firming, guidance is rising, and execution looks back on track after a tough 2024. With short interest still around **28 % of float**, any sustained bid could squeeze this one higher. >

Potential_Tap1331

nota alam kagum azlan ismun kerana mutu kerja setiap mereka di premis perdagangan setiap mereka -- GENG MFD BONUS 36 BULAN hal doa mengena orang sesiapa syak mohon penulisan untuk Azlan Ismun boleh cari geng siapa jua kerja kilang yang kenal nama Azlan Ismun ada yang lari negara ada yang buat jenayah pelik ada yang jual berniaga apa entah ada yang geng polis kenapa geng industry security cari Azlan Ismun mohon sesiapa pandai baca batin periksa hal rumah tangga mereka hal anak-anak mohon rujuk senarai kemahuan mereka FAISAL DARUS KANCIL UBAN PEMINAT WAHEEDA KANCIL GOLD MACAM TURBO GENG SESIAPA PERNAH SERUMAH SEWA AZLAN ISMUN GENG ITM SENDIRI PERNAH CUBA KILANG AREA SEKSYEN 16 SEMASA BARU DITENDANG ITM • SEKADAR KISAH LAMA. AKU TAK KESAH. TIADA APA BERLAKU. AKU TERNAMPAK IKLAN KOLEJ SWASTA DALAM HARIAN METRO dan tambahan mereka

Revfunky

APA

milkman1927

I want a 5 page essay in APA format about why you haven't bought gold yet

UshijimaX

RPA dev here using UiPath daily. You’re absolutely right about this. The “just build it yourself” argument misses the forest for the trees. Sure, any decent dev team could recreate these integrations. But enterprise software isn’t about what’s technically possible, it’s about what’s economically practical. UiPath’s real advantage isn’t the tech itself - it’s that they’ve already done the grunt work. Those SAP connectors? Battle-tested across thousands of deployments. The document processing? Trained on millions of real invoices, not synthetic data. The orchestration layer? Actually handles the messy edge cases that only show up at scale. The low-code angle is honestly genius from a business perspective. Instead of competing for scarce AI engineers, they’re enabling existing business analysts to build automation. That’s a WAY bigger TAM. What really makes me bullish though: they didn’t just lead in RPA - they basically owned the category. Now with APA (Agentic Process Automation), they’re doing it again. They’re not adapting to a trend, they’re defining where enterprise automation is headed next. The migration lock-in you mentioned is real, but I see it differently. Companies on legacy UiPath are the perfect customers for their new platform. The upgrade path is way smoother than ripping everything out for a competitor. Been working with their tools for years and seeing the APA stuff firsthand - the foundation they built with RPA actually translates really well. Same playbook, way bigger opportunity 👀​​​​​​​​​​​​​​​​

Affectionate-Idea690

so APA, Paccar, BA and others leading Spy, interesting....

Revfunky

CTRE- senior care real estate has been making me a fortune. I am also expecting another dividend increase soon. ARCC- The biggest, best BDC in the business. Turn on the Drip and enjoy the ride. I also have a unicorn pick. These come around every once in a while and usually you can count the number of unicorns on one hand. The last unicorn pick turned out to be a ten-bagger Rolls Royce (RYCEY.).We got in at the $1-$2 range. Unicorns create life changing money. As of right now I found 1 unicorn out of 23,281 stocks. I won’t bury the lead. APA is an oil and gas play that has cash flow coming in the doors. Just as important nobody is talking about which is exactly where I like to be. I do suggest using a 25% trailing stop to protect your principal.

Logical-Contest-4448

DD: Permian Resources ($PR) – Delaware Basin Pure-Play With Room To Run ⸻ Intro Permian Resources (ticker: PR) isn’t some random E&P chasing scattered acreage. They’re the largest pure-play operator in the Delaware Basin, which is the western half of the Permian Basin (West Texas + Southeast New Mexico). If you’ve followed shale at all, you know the Delaware is the crown jewel — some of the best rock in North America, stacked pay zones, great infrastructure, and tons of room to drill. PR has been growing into this position through smart acquisitions and strong operational execution, and right now they look set up to benefit from both scale and efficiency. ⸻ Why Care? 1. Acreage & Focus – Over 470,000 net acres in the Delaware Basin, all contiguous and in the “core of the core.” They don’t waste time on fringe plays. 2. Low Costs – They’ve been steadily bringing down lease operating expenses and drilling costs. That’s crucial in shale, because cost creep kills margins when oil dips. 3. Acquisition Game – PR just bought $600M worth of acreage and wells from APA in New Mexico. This wasn’t random land grab — it’s right next door to PR’s existing operations, meaning they can slot it in seamlessly. 4. Production Growth – That deal and ongoing development allowed PR to raise their 2025 oil production guidance to ~178,500 barrels per day. More oil, same infrastructure, same crews = more cash per dollar spent. 5. Shareholder Returns – Base dividend of $0.60 annually (~4% yield). They also buy back stock opportunistically when it trades cheap. ⸻ The APA Bolt-On This deserves its own section. In June, PR closed a deal with APA (Apache’s parent) to acquire ~13,000 net acres and ~12,000 barrels of daily production. Why it matters: • The acreage is directly next to PR’s current blocks in Lea and Eddy counties (New Mexico side of the Delaware). • Integration is straightforward — same crews, pads, and infrastructure. • Production bumps up right away, without them needing to drill new wells. Most acquisitions in shale destroy value because they’re expensive or far from your core. This one is the opposite: it’s accretive to cash flow and strengthens PR’s position as the top Delaware Basin operator. ⸻ Financial Health PR isn’t over-levered. Net debt is about 1x EBITDA, which is conservative compared to peers. They also just got an investment-grade rating, which lowers their cost of borrowing. That matters if oil gets volatile again — they won’t be forced into fire sales or equity raises. They’ve been printing solid free cash flow each quarter, even at mid-$60s oil. That means the base dividend is safe, and there’s room for buybacks and debt paydown. ⸻ Oil Price Sensitivity This isn’t magic — PR still lives and dies by oil prices. If WTI drops back into the 50s, free cash flow takes a hit. But because their acreage is in the Delaware core, they can survive downturns better than most peers. At $75 oil (a reasonable mid-cycle number), PR throws off well over a billion in free cash flow annually. Put another way: at today’s ~$14 stock price, the market is valuing them at a high single-digit free cash flow yield. If they just keep executing and oil holds steady, there’s a case for the stock in the $20 range over the next year or two. ⸻ Long-Term Bull Case • The Delaware Basin isn’t going away. It’s the most economic shale play in North America, and PR owns some of the best acreage in it. • They’ve proven they can integrate acquisitions without blowing up costs. The APA deal shows discipline. • Balance sheet is clean, dividend is covered, and management owns a big stake — they’re aligned. • As pipelines and marketing contracts shift more barrels to Gulf Coast pricing, PR should realize better netbacks (meaning higher prices per barrel compared to peers stuck in Waha discounts). ⸻ Risks • Oil price risk – obvious, and the biggest one. • Execution risk – if drilling or integration slips, costs can creep up fast. • Macro/regulation – federal regs in New Mexico or broader Permian could add headaches. ⸻ Bottom Line Permian Resources is one of the most compelling mid-cap E&Ps out there: pure Delaware Basin, low costs, smart acquisitions, shareholder-friendly capital returns, and a balance sheet that can handle oil price swings. At ~$14/share today, the market is pricing PR like a steady operator, not like a company that just grew production, raised guidance, and set itself up for higher netbacks in 2026. If oil stays anywhere in the $70–80 range, the math points to upside into the $20s, plus you’re paid a dividend while you wait. I’m long PR. Not financial advice, just sharing my DD.

Altruistic_Swim_3852

LEAPS!! long expiration contracts on out of the money! Believe me or don’t I don’t care 😂 it changed my life! Cgnx, APA, SSRM, also! SPY expiring after the fed (cut) meeting this month!

Reasonable_Roger

Holy shit some judge just shit all over 🥭. Who would have thought that going to legal war with the best lawyers in the world would be a bad idea. Anyway, SPY 648. Burroughs wrote that her review of the administrative record “makes it difficult to conclude anything other than that Defendants used antisemitism as a smokescreen for a targeted, ideologically-motivated assault on this country’s premier universities, and did so in a way that runs afoul of the APA, the First Amendment and Title VI,” she wrote, citing federal and constitutional law.

iamprostoman

Oil is hell cheap, keep loading already for a while. OXY to some extent, but also CIVI and APA.

andtoig

This is a really good point and I didn't know about the 20% rule. Counterpoint though, a lot of the companies in the S& P 500 you've probably never heard of, they suck, and they aren't really making any money right now, so it makes sense that the extremely profitable mega caps at the top would have a disproportionate share of the value. Bottom four are: Lamb Weston, Eastman Chemical company, APA corporation, and MarketAxess. I don't know much about any of them but I'm pretty sure that Nvidia and Netflix will give a better return on invested capital Objectively, the situation that we're in leads itself to a more unstable economy, so I'm not saying it's good. I'm just saying that a small number of companies are WAAAY better at making money than most of the rest

large_crimson_canine

Just go naked calls on APA it’s virtually guaranteed to profit

large_crimson_canine

Just do APA it’s a remarkable shitco. So remarkable in fact you could probably just go naked altogether.

anonymous9828

> where the next POTUS can just rescind it idk, there's always a judge out there that then blocks the rescission using some APA or "arbitrary and capricious" argument

Ancient-Neat2439

APA apache oil good dividends

Final_Reception1319

Again ad hominem attacks. I would expect nothing less from someone filled with hate. I’ll be concise since you lack the ability to want to read or find common ground. 1. It’s a simplistic way to look at the picture as a whole as these are principles taught in macro and micro economics. They wouldn’t be losing profits out of the goodness of their hearts. They wouldn’t be losing money because people don’t want to pay the newly increased prices. Never said I was in support or against Trump. I’m speaking to economic principles for anyone to read and get a different perspective as a lot of people want to argue that we shouldn’t allow a president to put tariffs on countries. They do have a choice. Just because we have a majority of products from China, doesn’t mean that as consumers we are forced to pay for them. You are making the assumption that because they want the product and have paid for it, they will continue. 2. I am not just waving my hand at how hard it would be to set up an infrastructure to support more manufacturing within the US. As anyone who has worked in the private sector knows, if you want something done fast you can pay and have it done. I can’t speak to the people in government or these other companies dragging their feet. If I was getting a subsidy over a certain period of time no matter how little progress I made in developing the infrastructure, I would drag my feet too to get paid to do so little with no incentive. 3. Instabilities are for sure a concern. But what also drives up concern is misinformation from news outlets, people online, etc. I am in no way arguing for or against the President. But not having respect for either candidate or political party in office is why we are currently here within our culture and why we have huge division. I think people on both sides of the isle are bad and that the reason we have a party system is for division. Instead of attacking, if you used your passion with other people to be productive and formulate solutions, our society might actually progress versus huge division and hate. 5. I apologize if I made an ill assumptions towards you. When reading your original response with the ad hominem attacks, I made it a point to address certain things in a certain way which you have every right to point out in regards to me speaking about AP English or whatever other arguments I made. However, that doesn’t give you the right to call names, throw a fit and try to attack me over a keyboard, and just because I’m not writing a comment on Reddit in MLA or APA format after explaining that I can, lends it self to yet again an ad hominem attack. Just because I make things simplistic in text doesn’t mean I don’t understand the complexity or nuance of a situation.

MethylBenzene

Ah, my morning reading comprehension isn’t there this morning. I do think that industry level estimates might be better suited as the methodology appears to be picking up on tariff sensitivity in specific groups i.e Halliburton, Schlumberger, DiamondBack, APA, Devon are all in the hydrocarbon business, but the approach is better founded than it seemed on a first glance.

QuantWizard

Since the tariffs have caused the markets to go both up and down, indicator variables don’t work. I’m simply measuring whether stocks have a higher beta on days with tariff news. Given that I’ve identified 43 days with such news YTD, the estimates are pretty stable, t-stats are very high and significant actually. For example, t-stat for APA Corporation is 3.62. For Halliburton it’s 4.11. For Skyworks Solutions it’s 2.78. Etc.

PuzzleheadedNail3343

M is in the same vein. Others to look at that I don't see mentioned elsewhere are AES, APA, and ETHA.

JellyfishPlus2182

I’m riding the AMD train while it’s on the way up and once my trailing stop loss hits, I’ll probably go into APA.  Solid financials and a good dividend.  

large_crimson_canine

If you go APA get ready to jump out fast. Still an extreme shitco and the market still hates them for Alpine High.

HMWhosit

Why APA?

rugerduke5

APA

GeorgeWBook

By committing to a week-long ritual of preparing and consuming green bean casserole, he’d not only be nourishing his body but aligning his portfolio with the spirit of abundance and discipline. The casserole, rich in tradition and cream of mushroom prophecy, becomes a talisman for commodity strength. Each bite channels bullish energy into crude oil, ignites gold miner momentum, and infuses copper markets with hearty Midwestern resolve. As he stirs those beans each night, he’s stirring market sentiment in his favor. By Friday, APA breaks out, XOM surges on refinery demand, and GDX finally realizes its destiny. The casserole never misses.

fartfuck43

Sure there’s leeway but they need to follow the administrative procedures act, which they haven’t been doing. So maybe “without authority” isn’t quite the right phrase, but “without following proper legal procedure” is pretty incontestable no? Canceling contracts based on personal vendetta (whether to Harvard or Elon Musk) violates APA.

tandoori_taco_cat

Be sure to use APA when citing tik tok in your political manifesto.

eddynetweb

Trump's team in both terms seems to struggle to follow the APA, I guess it takes too long to have concepts of procedures.

MayoSucksAss

Damn was that APA or MLA?

bsport48

And how do you understand the APA...?

KAI5ER

I did some furious digging and with some AI help Ive put this together. # Legally speaking: There is **no hard deadline** that compels the DEA to rule on an interlocutory appeal within a specific time frame. Federal agencies often operate with broad discretion and flexible internal timelines, especially in administrative matters like this. # Practically speaking: There are a few constraints — but they're **soft constraints**: 1. **Administrative Law Judge Oversight** Judge Mulrooney could eventually apply pressure if he feels the DEA is intentionally stonewalling. But so far, he's deferred to the process and merely requested status updates. 2. **Public and Political Pressure** While not legally binding, media attention, political lobbying, or pressure from Congress/the White House can **accelerate action**. However, these are external levers, not mandates. 3. **Judicial Review (in theory)** If the DEA *never* rules and parties with standing believe that inaction is effectively a denial, they may be able to challenge the delay in federal court under the **Administrative Procedure Act (APA)** — arguing that the agency is engaging in "unreasonable delay." But courts are generally **reluctant** to interfere in ongoing administrative processes unless the delay is egregious (e.g., years without action).

Specific-Can-2012

oil is in free fall. holding APA puts rn bc they are loaded with debt and cash flow negative with oil below $61. google oil producers, do some research, grab your balls and make a play

Specific-Can-2012

dance for me orange man, dance for me. holding APA puts, they cash flow negative when oil is below $61 and loaded with debt.

Specific-Can-2012

make it rain orange man. oil drops to 55 ima get my baby mama a house. holding puts on APA.

Specific-Can-2012

let it rain!!!!!!! holding APA puts yo. cash flow negative when oil is below $61 and loaded with debt.

Revfunky

I’m day trading and adding to long term holds. I buy when the VIX hits 40. I’m buying ARM-NET-PSHZF- CRSP-APA.

Didntlikedefaultname

I think both Pypl and Dell actually have a lot of potential upside and strong core businesses. Same with FedEx, especially as the postal service continues to be eroded. APA is a much more speculative play. Surprised to hear you say Amat and NVDA are terrible

Didntlikedefaultname

I bought amd, Pypl, Dell, FedEx and APA. I have dry powder and am watching Amat, amzn, and NVDA. Of course qqq and voo as well

mr_molecular

I was trying out the new release of Grok 3.0 and asked this question, thought it was kind of interesting. Trump signed ENSURING ACCOUNTABILITY FOR ALL AGENCIES EXECUTIVE ORDER February 18, 2025 does this mean the DEA must submit any rescheduling changes to Trump before issuing final rule? Yes, based on the information available and the context of the Executive Order signed by President Donald Trump on February 18, 2025, titled “Ensuring Accountability for All Agencies,” it is reasonable to infer that the Drug Enforcement Administration (DEA) would be required to submit any rescheduling changes, such as those related to marijuana or other controlled substances, to the White House for review before issuing a final rule. This conclusion stems from the stated intent and scope of the Executive Order. According to available details, the order mandates that *all federal agencies*—with no explicit carve-out for so-called independent agencies except for the monetary policy functions of the Federal Reserve—must submit draft regulations for White House review. The order emphasizes that all executive branch officials and employees are subject to the President’s supervision under Article II of the U.S. Constitution, which vests executive power in the President. This includes the DEA, which operates under the Department of Justice, an executive branch agency directly accountable to the President through the Attorney General. The Executive Order specifically aims to rein in agencies by requiring them to: 1. Submit draft regulations for White House review. 2. Consult with the White House on priorities and strategic plans, with performance standards set by the White House. Given this framework, any significant regulatory action by the DEA, such as issuing a final rule on rescheduling a controlled substance (e.g., marijuana, which has been under consideration), would fall under the category of a “draft regulation” or a major policy decision requiring White House oversight. The process of rescheduling involves rulemaking under the Administrative Procedure Act (APA), and final rules are the culmination of this process. The Executive Order’s directive to ensure accountability and oversight suggests that the DEA could not independently finalize such a rule without prior submission to and approval from the White House, likely through the Office of Management and Budget (OMB) or another designated review process. Additionally, the timing aligns with ongoing discussions about DEA rescheduling efforts. The DEA had delayed a public hearing on marijuana rescheduling from December 2024 to early 2025 (potentially January or February), and this Executive Order, signed on February 18, 2025, would likely apply to any final rule still in development or pending issuance at that point. The order’s emphasis on White House control over agency actions reinforces the idea that Trump intends to centralize decision-making, particularly on high-profile or controversial issues like drug policy. In summary, yes, under the Executive Order signed on February 18, 2025, the DEA would most likely need to submit any rescheduling changes to President Trump (or his designated representatives in the White House) for review and approval before issuing a final rule, unless the rule was already finalized and published prior to the order’s enactment. This aligns with the broader goal of ensuring all agency actions are accountable to the President’s supervision.

flagrande

So true! I bought APA during the COVID drop for $5, sold at $20 and missed it 10x-ing or more. Same with Cal-Maine and some others. Just buy and stop messing is the way many times.

LabDaddy59

I'm a fan of its near twin -- the credit put spread. Agree with the $1 wide comment. Also, I wouldn't be trading APA due to its low volatility and low liquidity. Especially for a 52% PoP. Similar comments re: DG.

value1024

"Bro, make those spreads wider! Like a lot wider. A $1 spread is a blowup waiting to happen" That is a different trade. How would you trade these 2 examples with APA and DG 2/21 bull call verticals?

zzzzzz808

APA green

Megaloman-_-

Buy now DVN and APA, thank me later

Notoriolus10

Because nobody read the article and the headline is clickbaity: They’re not suing to stop these stress tests (in the complaint they agree that they’re necessary). They complain about the fact that when the Fed decides to raise or lower capital demands for certain banks after a stress test, they don’t explain the reason why. From the complaint: >Federal regulations in an area this consequential should be adopted in a manner that complies with the requirements Congress laid down to ensure fair, rigorous rulemakings and rational results. >The current stress-testing process falls short of these requirements.Adopted in secret, it produces vacillating and unexplained requirements and restrictions on bank capital. The goal of this suit is to ensure that, going forward, bank capital requirements are established in a transparent manner, with public input, in accordance with the Administrative Procedure Act (“APA”), the Due Process Clause, and the standards our democracy employs to better the law through participation of the public.

CosmicSpiral

No, specifically pick companies according to the criteria listed in the original post. I ran this recently on SO, APA, DG, and WYNN.

Personal_Effective21

Nice list, should also check out Pharmala Biotech (CSE:MDMA) (OTC:MDXXF) Manufacturer and drug development of GMP MDMA- Primarily for PTSD therapy, other uses being studied as well. This company is primed to explode with the recent shift in healthcare in the United States under the Trump Administration. (Pro psychedelic therapy) With Lykos (MAPS) taking a step back after the FDA decision it puts Pharmala in a unique position. They are currently the top supplier of GMP MDMA globally. They have recently just signed supply contracts with institutions such as: Johns Hopkins, Harvard, Yale, Mount Sinai, etc. The new psychedelic center at Mount Sinai is funded by the VA, who recently just announced yesterday funding of 1.5M for the first study of this in over 5 decades. The tides are starting to shift and this is just the tip of the iceberg for what could be to come. They have also just recently signed an LOI with an institution to supply their clinical trial in exchange for the full data license of the results. (Expected to be finalized prior to 2024 calendar year) The supply side is great for revenue but they are also in the works of kicking off their P2 trial for their molecule (APA-01). This is where the potential for the big money is. The FDA's large concern of MDMA therapy was the safety of using generic MDMA as there are a few side effects associated with its use. Pharmala's molecule has been proven to mitigate these side effects with the use of their own molecule which essentially is a form of MDMA that still gives the effective feeling of MDMA but eliminates the risk of side effects. Pharmala also has a JV in Australia (Legalized MDMA therapy July 2023) with Cortexa. It was a slower rollout than expected although it is ramping up as Cortexa's recent update showed an increase in patients and training for licensed practitioners. They currently have an agreement for onshore manufacturing there.

phatbob198

Thanks for sharing. >**The Government’s response** (Government EPM Response or GEPMR) **to the Ex Parte Motion contains bold declarations** that the “DEA has not engaged in any ex parte communications” and that it “unequivocally denies any and all allegations of ex parte communications.” GEPMR at 3, 5. **Regrettably, these seemingly courageous proclamations are quickly all but eviscerated by the Government’s surprising qualification** that this proclamation of innocence extends only to the “DEA counsel of record”^3 at the time the GEPMR was filed, none of whom apparently had any contact with the matter at the time of the alleged ex parte communications. 4 Id. at 2. **Thus, the Government defended against an allegation that was never actually leveled, and never dealt with the true gravamen of the factual allegations of the EPM. Stated differently, the Government responded to an allegation that it created, not the one that was in issue**. >As discussed, supra, the applicable APA provisions are not so slender or lacking in common sense as to limit their applicability to a Government trial team who was never alleged to have made the communication in the first place. In its peculiar, semi-blanket denial, the Government did not happen to address staff members who actually may have made the purported communication, or those who may have been advising the Administrator at the time she was making decisions about whether there would be a rescheduling action, and who (if anyone) would sign the NPRM. The APA ex parte prohibitions are sufficiently robust to extend to any “employee who is or may reasonably be expected to be involved in the decisional process of the proceeding[s.]” 5 U.S.C. § 557(d)(1)(A)-(C). The applicable time period covers the earliest of when proceedings are noticed (here May 21, 2024) or when the communicator had knowledge that it would be noticed. Id. at § 557(d)(1)(E). It would be disingenuous to suggest that the decision to issue the NPRM was made on the date it was signed by the Attorney General, with no input from DEA, the subordinate agency that is the repository of all the authority to act under the Controlled Substances Act... >While the EPM may have weaknesses in this regard, there is likewise no indication in its GEPMR that the Government has made even the mildest attempt to ascertain the truth and disclose it to the public and this tribunal...

phatbob198

>...Just two days after a motion was filed with DEA Administrative Law Judge (ALJ) John Mulrooney, challenging the agency’s role as a “proponent” of the proposed rescheduling rule, the official responded with a filing that expressed mixed opinions about the underlying arguments. >The brief order emphasized that the case was unprecedented, with attorneys for two cannabis organizations asking the DEA tribunal to “unilaterally remove the DEA, its counsels, and its Administrator” from the rescheduling process ahead of an initial hearing on December 2. >That request from Hemp for Victory and Village Farms was largely based on an allegation that DEA officials “engaged in ex parte communications regarding the merits of the proposed rescheduling” in violation of federal Administrative Procedure Act (APA) statute. The petitioners have asked that DEA be replaced by the Justice Department or Hemp for Victory as the “proponent” of the rule... >**The judge, in turn, said that the prospect of removing an agency head from rulemaking that it is responsible for overseeing would likely, “and correctly,” be deemed beyond the ALJ office’s jurisdiction**. >**“That said, this tribunal does retain sufficient authority and independence to tender recommendations to the Administrator, no matter what discomfiture those recommendations may inflict upon the Agency or its Leadership,”** it said. >“While deciding nothing at this juncture, that aspect of the Motion’s request that one of the Movants supplant the Agency as the proponent of [proposed rule] may arguably be vulnerable to a characterization of being unserious. The Motion propounds no hint of authority for such an unprecedented action, what control could or should be exercised over that Movant who replaces the Government, or (probably more importantly) what would happen next if this unique request was actually granted.” >Mulrooney added that, even if the DEA “may not (yet?) be convinced about the correctness of the proposed rescheduling action pending a review of the recommended decision,” the “efficacy” of swapping the DEA head for a proponent who is “absolutely firmly entrenched in the one side of the issue” is “not altogether clear from the Motion.” >“But again, nothing is decided here,” he said. Regardless of the potential efficacy of the procedural request, the DEA judge did say that, **“on the other side of the coin, the allegations regarding alleged improper ex parte communications are serious, and the concomitant obligations to memorialize and report such communications set forth in the APA and the regulations are by no means couched in permissive language.”** >That’s a reference to the motion’s allegations that DEA may have violated certain laws while conducting the rescheduling review, including “unlawful” communication with the prohibitionist organization SAM. >The filing included screenshots of social media posts where the group’s president, Kevin Sabet, indicated he had private conversations with DEA officials about the rescheduling effort as SAM rallied opposition to the reform and urged the agency to keep marijuana in Schedule I. >One week prior to DOJ’s publication of the proposed rule, Sabet posted on X that he could confirm Milgram wouldn’t sign the notice, citing “two confidential sources inside DEA and another outside DEA with intimate knowledge.” >The DEA judge said that the government is invited, but not obligated, to respond to the motion’s allegations by November 25. >**Shane Pennington**, one of the attorneys who filed the underlying motion regarding DEA’s role in the hearing, told Marijuana Moment that while he **disagreed with certain aspects of the judge’s new order, he was encouraged that it appears Mulrooney is taking the matter seriously—evidenced in part by that fact that the motion wasn’t summarily dismissed**...

phatbob198

>A Drug Enforcement Administration (DEA) judge has officially ruled on which of the agency’s selected witnesses for a marijuana rescheduling hearing will be able to participate, while laying out the procedure for the administrative process—including how pro- and anti-reform speakers will be able to cross-examine one another. >The order also briefly addressed a motion filed on Monday on behalf of one of the participants that argued DEA itself should be removed from the hearing as a “proponent” of the rescheduling rule due to alleged statutory violations, including “unlawful” communication with the prohibitionist group Smart Approaches to Marijuana. The judge said that he found the motion “wholly unpersuasive” but would formally rule on it separately. >In any case, with a December 2 preliminary hearing on the rescheduling matter just weeks away, DEA Administrative Law Judge (ALJ) John Mulrooney’s order on Tuesday lists the agency’s chosen witnesses and assesses their legal standing for participation under the Administrative Procedure Act (APA). A key component of the standing determination was whether the participants could establish that they’d be meaningfully [harmed?] >Three of the 25 witnesses who initially asked to take part in the proceedings withdrew their requests, and another two were deemed ineligible to participate. The DEA judge determined that several of the designated participants (DPs) technically lacked standing under the tribunal’s interpretation of the law, but said that they could still join the hearing. >“Standing to appear in an APA agency proceeding can differ markedly from the rigid standing requirements incumbent on those seeking relief in the federal courts,” the order says. And while the agency is required to include certain witnesses with demonstrable interest in the proposed rule, “this is not to say that everyone must be inexorably welcomed to appear before every agency on every issue that touches widely on society or tugs at the heartstrings.” >The ALJ was not provided with copies of the original requests to participate in hearing that were submitted to DEA Administrator Anne Milgram, it notes. Instead, the judge based decisions on supplementary information his office requested after finding that the administrator’s letters regarding the witnesses it chose were insufficient. >All told, the witnesses that are moving forward seem to skew on the oppositional side of the proposed marijuana reschedule rule, but that largely reflects the rules for determining standing, which generally prioritizes those who claim they would be adversely impacted by a proposed rule. >Law enforcement organizations, prohibitionists and Nebraska’s attorney general are among those who will testify at the hearing, for example. >On the pro-rescheduling side, entities like the National Cannabis Industry Association (NCIA), the Connecticut Office of Cannabis Ombudsman and Hemp for Victory have been cleared to participate, despite the fact that the judge determined that the latter two lacked standing. >With respect to NCIA, the judge said that one of the group’s claims of standing was “more nuanced and more persuasive” than its broader position in support of rescheduling. That is, NCIA “posits that a number of its members would be adversely affected by a new definition of tetrahydrocannabinol which is incorporated” in the proposed rule. >However, a “significant weakness in this position is that NCIA has not specifically alleged that any of its members are currently utilizing any particular substances that would be affected (a deficit that could conceivably undermine its standing argument in this regard),” the order says... >At the hearing, DEA will be allowed to bring as many witnesses as it wants, while each of the other designated participants are limited to providing testimony from a single witness. >The order also describes the structure of the hearing. First, the government will make its case on the proposed rescheduling rule. Then, pro-rescheduling witnesses will get the chance to speak for up to 90 minutes, followed by the anti-rescheduling participants. >“Anti-Rescheduling DPs may cross-examine all Government witnesses and all Pro-Rescheduling witnesses. Witnesses presented by the Anti-Rescheduling DPs may be cross-examined by the Government and ProRescheduling DPs,” the order says. “In all cases, cross-examination will be limited to approximately twenty (20) minutes per witness for each authorized cross-examiner...”

jmu_alumni

“The proponent of the rule designation is no mere technicality. Because that party bears the burden of proof, this Tribunal has permitted them more witnesses and more counsel at the hearing. Given its steadfast opposition to the proposed transfer of marijuana to schedule III, DEA is the last party on Earth that should be permitted to act as proponent of the Proposed Rule in these proceedings.29 Not only would permitting DEA to remain in that role violate the APA and DEA regulations, but it would also vitiate any chance this Tribunal might have of ensuring a fair and transparent hearing or developing a complete administrative record. After all, the entire point of the formal rulemaking process is to put the Proposed Rule to the test of a rigorous adversarial process. If the supposed champion of the Proposed Rule is, in fact, its greatest opponent, however, the entire process will be a farce. ”

jmu_alumni

“Because DEA is the opponent of the Proposed Rule and not its proponent, the Agency cannot bear the burden of proof in these proceedings. Under the APA and DEA’s own regulations, that role must be filled by a party that actually proposed a rule transferring marijuana to schedule III. There are only two entities that qualify: (1) DOJ, the agency that actually proposed the NPRM, 21 and (2) Hemp for Victory, the only party to these proceedings that has, in fact, filed a petition and proposed a schedule III rule.28 Therefore, unless DOJ is willing to enter an appearance in these proceedings, this Tribunal must permit Hemp for Victory to act as proponent of the rule going forward. “

overitallofit

If you still like the companies, buy the equal amount to what you have now. So if you have 50 shares of APA, buy another 50 shares. In 30 days, sell the original shares. Take the loss on your taxes and you still have the same portfolio.

organicclover

I didn’t say transgenderism isn’t real. I said plastic surgery and HRT for children is not the correct route for treating a mental health condition. I am not a bigot to call it a mental health condition, that is how is defined by WHO, DSM and APA. My son’s blood disorder is treated by a direct replacement of the protein his body doesn’t make. Unfortunately you can’t stick a different chromosome into a trans person, so the best we can do is cut off their penis and give him estrogen. There is much debate in the scientific community on how to properly treat transgenderism, and we shouldn’t be experimenting on children.

Mace-Dragon

They also run oil and gas company APA, down almost 10% today.

perfectdark89

Bears don’t follow APA style

Defol-420

sorry bro APA can't time neeko ult

a51c30

Increase in P/E ratio cold be explained by the proliferation of index funds and retail investing over the past decade and a half. If more money comes in it has to go somewhere the mag 7 and s&p 500 is a self fulfilling prophecy in this respect. In demand companies get more attention which increases the premium on their shares, combine that with the set it and forget it “invest in everything with the highest market cap” index investing which is the most popular these days and you have an increase in overall PE as the largest weighted companies demand even more money from every dollar put into broad market index funds as the attention and short term performance attracts more growth investors. Ever heard of APA Corporation? How about Catalent Inc? Well if you bought any SP500 index fund you bought a little bit of that too. everyone has. So there’s a little bump on the premium for those smaller companies there too and as the heavy weighted companies eat up market cap and consolidate with other like minded successful enterprises through M&A you get a lower quality bottom of the list than you had previously, except they’re being bought more aggressively than a long time ago by passive investors who “buy the market.” The introduction of ETFs, the move to defined contribution from defined benefit retirement plans, and the increased popularity of retail investing created a brand new environment in the market never seen before. Unlike the Great Recession, Great Depression and tech crash, these are not bubbles as much as they are paradigm shifts in how we as a society invest our personal wealth. The market is simply more busy with more players than it has ever been before. That may be something to consider when looking at the increased PE you mentioned. As for the banks and their losses. These treasuries they hold are the safest investments you can purchase. As such, the banks have the ability to mark to maturity if they can verify their full intent to hold them to maturity. While your right that if there is a bank run there could be forced liquidation and trouble, your wrong in saying there are unrealized losses on their books because these losses can’t materialize in the first place. Regardless, as interest rates are cut these t notes will increase in value. Now for interest rates. The printing of money does not itself create inflation and the inflation phenomenon is not as simple a supply and demand like many think. The increased supply of money does not create less demand for it and as a result increase prices. It’s increased credit that promotes consumer spending and increased government spending that adds money to the private sector that creates inflation. So to say rate cuts are not possible is not all that accurate and it really depends on whether and when we will arrive at the feds neutral interest rate.

Big_data_007

Right now the most compelling E&P in my opinion is is APA. Stock is ridiculously cheap. Very large lower cost Permian acreage and very promising 50% working interest in block 58 of coast of Suriname. APA could be the next Hess. If final exploration comes in even more favorable than expected by end of this year the stock could double overnight just based on future cash flows of the Suriname assets themselves.

Fun-Journalist2276

Another week another deal for PLTR with APA 

john2557

The majors will probably use this decline in oil prices to acquire more companies (APA seems like a prime candidate). I also think Buffet will use this opportunity (i.e. lower prices) to just flat out buy OXY at some point in the next year.

CosmicSpiral

To be perfectly honest? APA is a poorly performing E&P with several international assets in undesirable locations. Viper Energy is the opposite.

ComprehensiveKiwi489

I’m talking about compared to APA.

ComprehensiveKiwi489

Any reason why a stock like APA is down so much, even though a stock like VNOM is up over the last year? I’m also noticing that, although the price of oil has gone down so much, the oil giants are barely down.

Chance_Island2704

I know nat gas, energy being down, etc. but can someone talk me out of going long on APA with a PE of 2.75?

A-Wise-Cobbler

ALJ - Administrative Law Judges (The H is a typo) APA - Administrative Procedure Act

DEASqueezeAllComing

Could you please explain what does it mean and what does ALH and APA acronyms stand for (getting weird results on google)

Resi86

https://x.com/DrSashaWarren/status/1828531992691868027 “A final rule w/o a hearing, Sabet files suit claiming a violation of the APA with Trump’s former AG as counsel. A friendly court grants an injunction and the pre-election “final” rule is delayed years. I bet we arrive at an actual final rule earlier with an ALH.”

Quiet_Foundation6218

$APA long 150k 0:08 Reportedly considering sale of oil & gas assets in the Permian basin worth $1B - press (update) - mkt cap only 10b ...looking for$31.50 target

GeneralCody

https://preview.redd.it/z5q0hl1gj5jd1.jpeg?width=1170&format=pjpg&auto=webp&s=14d909ea5804808dece2169e6a4246f64f529f34 I guess I’ll cite my source. Mods do you want MLA or APA format?

GeneralCody

https://preview.redd.it/qeppiwnzi5jd1.jpeg?width=1170&format=pjpg&auto=webp&s=50fb8d0fc898f94de53d913024d37ec116a2206f I guess I’ll cite my source. Mods, do you want MLA or APA?

TomatoSpecialist6879

It's more like a midnight bar for normal bar goers and alcoholics, but some get more business from day traders since it's located near hotels day traders like to stay at(eg. APA hotel chains), or near hedge funds and banks. But I've been at a bar at Shibuya opened by a former hedge fund executive, it had TV screens showing movements of SPX, DOW, etc, he also had a Bloomberg Terminal which was pretty neato. But that was 12 yrs ago so I have no idea if he's still in business or not.

StonkGoUp

Idk who else uses MLA, all my homies fuck with APA

jmu_alumni

Just FYI for additional context: “I didn’t mention 90-day rev of final rule bc the 90-day window derives from EO 12866–an exec order that requires OMB rev of some rulemaking but expressly EXEMPTS rules made through formal rulemaking under APA secs. 556-57 from that requirement. See EO 12866, section 3(d)(1)... I didn’t mention 90-day rev of final rule bc the 90-day window derives from EO 12866–an exec order that requires OMB rev of some rulemaking but expressly EXEMPTS rules made through formal rulemaking under APA secs. 556-57 from that requirement. See EO 12866, section 3(d)(1)...” https://x.com/admindotlaw/status/1790580999828406364?s=46&t=zPyMS7ww1KmMmwwKd-prIw

therearenolighters

Alright ya lazy fucks, here you go [https://www.supremecourt.gov/opinions/23pdf/22-451\_7m58.pdf](https://www.supremecourt.gov/opinions/23pdf/22-451_7m58.pdf) And here is the fucking meat: >"Chevron is overruled. **Courts must exercise their independent judgment in deciding whether an agency has acted within its statutory authority**, as the APA requires. Careful attention to the judgment of the Executive Branch may help inform that inquiry. **And when a particular statute delegates authority to an agency consistent with constitutional limits, courts must respect the delegation, while ensuring that the agency acts within it.** But courts need not and under the APA may not defer to an agency interpretation of the law simply because a statute is ambiguous." The Controlled Substances Act authorizes the Attorney General to add, transfer, and remove drugs from the schedules using formal rulemaking procedures, see id. §§ 811, 812, and otherwise grants the Attorney General broad authority to take regulatory action consistent with the Act, see, e.g., id. §§ 821, 871(b). The Attorney General has in turn generally delegated these functions to the Administrator of the Drug Enforcement Administration (“DEA”). 28 C.F.R. § 0.100(b). So you guys tell me what are we so fucking scared about? Do you think that the Controlled Substances Act is ambiguous? Do you think the Attorney General and the DEA does not have statutory authority over this matter?

Hularuns

With natty gas this high, debt-ridden APA with its oil-light gas-heavy assets might recover from the lows it's been hovering at for months.

Rebelcr7

During a meth induced hallucination I learned what NVDA’s top will be, I’ll be making a DD post as soon as I figure out how to cite that source in proper APA style

ChiliConCaralho

APA in this case stands for American psychopaths association

LethargicBatOnRoof

APA is a style guide for how to format research/academic papers. It gives guidelines on how to cite sources, format things, etc. Most schools have a preferred style guide and you are required to do those things in a very specific way. The joke is essentially that a fever dream would never be an acceptable source.

Carlosmow7

Typically I do cite my visions in APA format, but I didn’t think it was necessary on Reddit.

_learned_foot_

Until congress acts yeah this is just APA, which means another notice and comment and the same president 3 months later can change their own mind.

AmericanSahara

Your right about Big pharma wanting to get people hooked for life. They, and the whole AMA, APA and ADA, capitalize on **treatments** instead of developing **preventions**. They banned appetite suppressants and banned fat blockers and sold insulin for decades. Now that price caps have been forced on insulin and other treatments, they suddenly sell GLP-1 stuff so they can get people hooked on $1000/month treatments for the rest of their life. Americans spend more on health care but they certainly are not more healthy. If big pharma really wanted to **prevent** obesity, they'd develop the PYY3-36 hormone that helps people who can't control hunger or portion size because their bowls always scream for them to keep eating. This hormone would allow people to control portion size, make the right choices and lose a few extra pounds and be able to control their food intake without having their blood chemistry messed up. I've never been fat, yet I've had to discover on my own how to control calorie intake because doctors or any medical expert or big pharma would **never** help me PREVENT being overweight. You are very evil by picking fights with people who can't control their eating behavior. There are about 10 different reasons why people can't control eating/activity. In most cases limiting calorie intake only makes them much more hungry and angry directly at YOU. And forced exercise only makes them more tired and hungry while people without the one of these disorders tend to feel refreshed by exercise. I think most people would feel very refreshed getting exercise in kicking your butt in a boxing match.

RandomGenerator_1

There is a lot of reading material on the APA judicial review process, and how courts can play a role. I am not worried.

purotaco

Listen here, snob, we ain't here for facts or friends, we are here for rumors and good times, brother! Take your APA Style Guide reading on the crapper self and please throw yourself out of the building. Mark. /s

NegotiationFuzzy4665

I’d like to say that Reddit users are the only social media users that actually give a shit about what it’s company does. The save 3rd party apps blackout didn’t work, but you didn’t see Twitter users doing anything when their site was thrown into a production blender by Elon. Our protests are useless but we Redditors are special in the sense that we put effort into our posts. Every site has bots, but every site also has users that post low effort content. A couple sentences at most. Here, we have subs of fans and experts that are willing to type out a properly cited APA essay on the most over-specific bullshit topic you’ve ever heard. That may be a little sad in some contexts, but it’s gold to search engines and AI. While we’re the worst user base to manage, we’re also easily the most useful. Not for advertising, but as a source for information. Don’t cite a Reddit thread though. The power of neckbeards; hard to manage, but crazy valuable. Good info and free moderation… hard to pass that up

Hularuns

APA (more nat gas exposure than peers while gas is super cheap) Lynas Rare Earths (China is flooding the market) BTI (long-tem marijuana legalization beneficiary, probably won't moon when the law is passed but big tobacco will ultimately take over)

Hularuns

MP Materials for growth. APA for value. Lynas Rare Earths for a bit of both.

Hularuns

APA down in the dumps left for dead at a 3 PE today. It's not dying. Buy!

Sziom

APA and DVN, with some southwest gas.

Snedaskinawood

APA all the way!

ub3rm3nsch

NSTGQ. I looked at the buyout figure. I looked at the number of shares. I looked at the fact that institutions aren't selling. These things are also being discussed on stock twits. In my opinion there is going to be a shareholder payout after the APA is settled that is multiples above the current shareprice.

WhisperNumbers

They dropped 22c today, so hopefully you avoided buying them. Tough to buy into weakness (APA has been trending lower since Apr 3rd). And with expiration so soon there's very little time for upside. Even if you went out further the average price move heading into earnings (May 1) is -2.9%. Tough to find anything positive about that play (other than they're cheap).

Megaloman-_-

Options are too volatile in this moment. Better to buy the underlying stock…. I opened positions in PBF, DINO, MPC, MRO, SM, EOG, APA, DVN, PXD